1,325
Participants
Start Date
March 24, 2022
Primary Completion Date
March 10, 2023
Study Completion Date
February 20, 2025
NmCV-5
NmCV-5 is a pentavalent meningococcal (A, C, Y, W, X) polysaccharideconjugate vaccine composed of capsularpolysaccharides (PS) from Neisseria meningitidis serogroups A, C, Y, W, and X individually conjugated to a protein carrier, either mutant diphtheria toxoid (CRM197) or tetanus toxoid (TT).
MenACWY-TT
MenACWY-TT (the comparator meningococcal vaccine) is a WHO-PQ quadrivalent meningococcal (A, C, Y, W) polysaccharide-conjugate vaccine manufactured by Pfizer.
Centre pour le Developpement des Vaccins du Mali, Bamako
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Emory University
OTHER